Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

m6A Modification Genetic Variants Associated with Autism Spectrum Disorder Risks.

Molecular neurobiology - 27 May 2026

Wang Haoxue, Zhao Shuai, Chen Yanlin, Hou Fang, Zhu Kaiheng, Liu Rundong, Xiang Zhen, Chen Qianhui, Fan Hong, Huang Mengyuan, Wang Zhike, Zhang Jiao, Wang Tianchun, Liang Xi, Zeng Xiaoxue, Gong Zhaohui, Li Li, Song Ranran

Abstract excerpt

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder with increasing prevalence and high heritability. As a key epigenetic mechanism in brain development and function, the specific mechanisms of N6-methyladenosine (m6A) modification in ASD remain unknown. This study conducted bioinformatics analysis of m6A-QTL data from Yoruba lymphoblastoid cell lines and the RMVar database to identify m6A-QTL SNPs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine
Share to Autism Spectrum Disorder

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Genetic Predisposition to Disease

Share to Genetic Variation

Share to Polymorphism, Single Nucleotide

Share to Quantitative Trait Loci

Share to Risk Factors

Source

Identifiers

PMID: 42201483
DOI: 10.1007/s12035-026-05962-1

Genes

LRP1
STAT6
THAP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

m6A Modification Genetic Variants Associated with Autism Spectrum Disorder Risks.PMID 42201483Read ↗

Integrative approaches to m6A and m5C RNA modifications in autism spectrum disorder revealing potential causal variants.Semantic proximity Read ↗

Expression Status and Potential Therapeutic Value of M6A in Autism Spectrum DisorderSemantic proximity Read ↗

Integration of multi-omics summary data reveals the role of N6-methyladenosine in neuropsychiatric disorders.Semantic proximity Read ↗

Identification of Methylation Markers for Diagnosis of Autism Spectrum DisorderSemantic proximity Read ↗

Genetic analyses support the contribution of mRNA N6-methyladenosine (m6A) modification to human disease heritability.Semantic proximity Read ↗

m6A-mRNA reader YTHDF2 identified as a potential risk gene in autism with disproportionate megalencephalySemantic proximity Read ↗

Genetic drivers of m6A methylation in human brain, lung, heart and muscle.Semantic proximity Read ↗

Genome-wide DNA methylation profiles in the raphe nuclei of patients with autism spectrum disorderSemantic proximity Read ↗

Epigenomic strategies at the interface of genetic and environmental risk factors for autism.Semantic proximity Read ↗

Family-Based Genome-Wide Association Study of Autism Spectrum Disorder in Middle Eastern Families.Semantic proximity Read ↗

Genetic Variants in METTL16 Affect the Risk of Non-Syndromic Orofacial Clefts.Semantic proximity Read ↗

Merging data from genetic and epigenetic approaches to better understand autistic spectrum disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.